Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis
- Autores
- Abeldaño Zuñiga, Roberto Ariel; González Villoria, Ruth Ana María; Elizondo, María Vanesa; Osorio, Anel Yaneli Nicolás; Gómez Martínez, David; Coca, Silvia Mercedes
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Aims: Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. Methods: We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. Results: A total of 51 studies were retrieved from the databases. Five articles were finally included in the data extraction and qualitative and quantitative synthesis of results. The overall risk of bias in the reviewed articles was established at low-risk only in two trials. The meta-analysis suggests that there is no benefit of convalescent plasma compared with standard care or placebo in reducing the overall mortality and the ventilation requirement. However, there could be a benefit for the clinical improvement in patients treated with plasma. Conclusion: Current results led to assume that the convalescent plasma transfusion cannot reduce the mortality or ventilation requirement in hospitalized patients diagnosed with SARS-CoV-2 infection. More controlled clinical trials conducted with methodologies that ensure a low risk of bias are still needed. The reviews of this paper are available via the supplemental material section.
Fil: Abeldaño Zuñiga, Roberto Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de la Sierra Sur; México
Fil: González Villoria, Ruth Ana María. Universidad de la Sierra Sur; México
Fil: Elizondo, María Vanesa. Universidad Catolica de Cuyo. Facultad de Ciencias Medicas. Instituto de Investigacion En Ciencias Biomedicas.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Osorio, Anel Yaneli Nicolás. Universidad de la Sierra Sur; México
Fil: Gómez Martínez, David. Universidad de la Sierra Sur; México
Fil: Coca, Silvia Mercedes. Universidad de la Sierra Sur; México - Materia
-
CLINICAL IMPROVEMENT
CONVALESCENT PLASMA
COVID-19
MORTALITY
SARS-COV-2 - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/150530
Ver los metadatos del registro completo
id |
CONICETDig_2c72eaab96b1ea512c8a2ababb4caddd |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/150530 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysisAbeldaño Zuñiga, Roberto ArielGonzález Villoria, Ruth Ana MaríaElizondo, María VanesaOsorio, Anel Yaneli NicolásGómez Martínez, DavidCoca, Silvia MercedesCLINICAL IMPROVEMENTCONVALESCENT PLASMACOVID-19MORTALITYSARS-COV-2https://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Aims: Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. Methods: We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. Results: A total of 51 studies were retrieved from the databases. Five articles were finally included in the data extraction and qualitative and quantitative synthesis of results. The overall risk of bias in the reviewed articles was established at low-risk only in two trials. The meta-analysis suggests that there is no benefit of convalescent plasma compared with standard care or placebo in reducing the overall mortality and the ventilation requirement. However, there could be a benefit for the clinical improvement in patients treated with plasma. Conclusion: Current results led to assume that the convalescent plasma transfusion cannot reduce the mortality or ventilation requirement in hospitalized patients diagnosed with SARS-CoV-2 infection. More controlled clinical trials conducted with methodologies that ensure a low risk of bias are still needed. The reviews of this paper are available via the supplemental material section.Fil: Abeldaño Zuñiga, Roberto Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de la Sierra Sur; MéxicoFil: González Villoria, Ruth Ana María. Universidad de la Sierra Sur; MéxicoFil: Elizondo, María Vanesa. Universidad Catolica de Cuyo. Facultad de Ciencias Medicas. Instituto de Investigacion En Ciencias Biomedicas.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Osorio, Anel Yaneli Nicolás. Universidad de la Sierra Sur; MéxicoFil: Gómez Martínez, David. Universidad de la Sierra Sur; MéxicoFil: Coca, Silvia Mercedes. Universidad de la Sierra Sur; MéxicoSAGE Publications2021-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/150530Abeldaño Zuñiga, Roberto Ariel; González Villoria, Ruth Ana María; Elizondo, María Vanesa; Osorio, Anel Yaneli Nicolás; Gómez Martínez, David; et al.; Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis; SAGE Publications; Therapeutic Advances in Respiratory Disease; 15; 6-2021; 1-111753-46581753-4666CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://journals.sagepub.com/doi/10.1177/17534666211028077info:eu-repo/semantics/altIdentifier/doi/10.1177/17534666211028077info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:42:05Zoai:ri.conicet.gov.ar:11336/150530instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:42:06.001CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis |
title |
Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis |
spellingShingle |
Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis Abeldaño Zuñiga, Roberto Ariel CLINICAL IMPROVEMENT CONVALESCENT PLASMA COVID-19 MORTALITY SARS-COV-2 |
title_short |
Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis |
title_full |
Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis |
title_fullStr |
Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis |
title_full_unstemmed |
Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis |
title_sort |
Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis |
dc.creator.none.fl_str_mv |
Abeldaño Zuñiga, Roberto Ariel González Villoria, Ruth Ana María Elizondo, María Vanesa Osorio, Anel Yaneli Nicolás Gómez Martínez, David Coca, Silvia Mercedes |
author |
Abeldaño Zuñiga, Roberto Ariel |
author_facet |
Abeldaño Zuñiga, Roberto Ariel González Villoria, Ruth Ana María Elizondo, María Vanesa Osorio, Anel Yaneli Nicolás Gómez Martínez, David Coca, Silvia Mercedes |
author_role |
author |
author2 |
González Villoria, Ruth Ana María Elizondo, María Vanesa Osorio, Anel Yaneli Nicolás Gómez Martínez, David Coca, Silvia Mercedes |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
CLINICAL IMPROVEMENT CONVALESCENT PLASMA COVID-19 MORTALITY SARS-COV-2 |
topic |
CLINICAL IMPROVEMENT CONVALESCENT PLASMA COVID-19 MORTALITY SARS-COV-2 |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Aims: Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. Methods: We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. Results: A total of 51 studies were retrieved from the databases. Five articles were finally included in the data extraction and qualitative and quantitative synthesis of results. The overall risk of bias in the reviewed articles was established at low-risk only in two trials. The meta-analysis suggests that there is no benefit of convalescent plasma compared with standard care or placebo in reducing the overall mortality and the ventilation requirement. However, there could be a benefit for the clinical improvement in patients treated with plasma. Conclusion: Current results led to assume that the convalescent plasma transfusion cannot reduce the mortality or ventilation requirement in hospitalized patients diagnosed with SARS-CoV-2 infection. More controlled clinical trials conducted with methodologies that ensure a low risk of bias are still needed. The reviews of this paper are available via the supplemental material section. Fil: Abeldaño Zuñiga, Roberto Ariel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de la Sierra Sur; México Fil: González Villoria, Ruth Ana María. Universidad de la Sierra Sur; México Fil: Elizondo, María Vanesa. Universidad Catolica de Cuyo. Facultad de Ciencias Medicas. Instituto de Investigacion En Ciencias Biomedicas.; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Osorio, Anel Yaneli Nicolás. Universidad de la Sierra Sur; México Fil: Gómez Martínez, David. Universidad de la Sierra Sur; México Fil: Coca, Silvia Mercedes. Universidad de la Sierra Sur; México |
description |
Aims: Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. Methods: We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. Results: A total of 51 studies were retrieved from the databases. Five articles were finally included in the data extraction and qualitative and quantitative synthesis of results. The overall risk of bias in the reviewed articles was established at low-risk only in two trials. The meta-analysis suggests that there is no benefit of convalescent plasma compared with standard care or placebo in reducing the overall mortality and the ventilation requirement. However, there could be a benefit for the clinical improvement in patients treated with plasma. Conclusion: Current results led to assume that the convalescent plasma transfusion cannot reduce the mortality or ventilation requirement in hospitalized patients diagnosed with SARS-CoV-2 infection. More controlled clinical trials conducted with methodologies that ensure a low risk of bias are still needed. The reviews of this paper are available via the supplemental material section. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/150530 Abeldaño Zuñiga, Roberto Ariel; González Villoria, Ruth Ana María; Elizondo, María Vanesa; Osorio, Anel Yaneli Nicolás; Gómez Martínez, David; et al.; Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis; SAGE Publications; Therapeutic Advances in Respiratory Disease; 15; 6-2021; 1-11 1753-4658 1753-4666 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/150530 |
identifier_str_mv |
Abeldaño Zuñiga, Roberto Ariel; González Villoria, Ruth Ana María; Elizondo, María Vanesa; Osorio, Anel Yaneli Nicolás; Gómez Martínez, David; et al.; Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis; SAGE Publications; Therapeutic Advances in Respiratory Disease; 15; 6-2021; 1-11 1753-4658 1753-4666 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://journals.sagepub.com/doi/10.1177/17534666211028077 info:eu-repo/semantics/altIdentifier/doi/10.1177/17534666211028077 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
SAGE Publications |
publisher.none.fl_str_mv |
SAGE Publications |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613326612463616 |
score |
13.070432 |